News

Bristol Myers Squibb has appointed Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, ...
Hovione and Firstgene Life Sciences have entered a strategic collaboration to advance Hovione’s virus-like particle drug ...
Alchemab Therapeutics, a next-gen biopharmaceutical company, has entered into a licensing agreement with Eli Lilly and ...
Clean Biologics, an international group providing services to the biopharmaceutical industry, appointed Laurent Claisse as ...
Ipsen, a global specialty care-driven biopharmaceutical company, has appointed Laura Réveillon, PhD as EVP, Strategy & ...
The partnership will prepare for Phase I preparations for Novelty Nobility’s bispecific antibody drug candidate.
The FDA has granted Fast Track designation to Italfarmaco S.p.A.’s givinostat for the treatment of patients with polycythemia vera (PV).